YOUR BUSINESS AUTHORITY

Springfield, MO

Log in Subscribe

Eli Lilly to buy Verve Therapeutics for $1.3B

Posted online

Eli Lilly has agreed to buy gene-editing startup Verve Therapeutics.

The deal is valued at up to $1.3 billion.

The agreement calls for an upfront payment of $1 billion, and $300 million will be paid out based on the completion of certain clinical milestones.

Read more from CNBC.

Comments

No comments on this story |
Please log in to add your comment
Editors' Pick
Open for Business: MD Hyperbaric

A provider of hyperbaric oxygen therapy opened its first Missouri location on Aug. 12 at 1316 E. Republic Road.

Most Read
Update cookies preferences